These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6187038)

  • 1. Kinetics of l-5-hydroxytryptophan in healthy subjects.
    Westenberg HG; Gerritsen TW; Meijer BA; van Praag HM
    Psychiatry Res; 1982 Dec; 7(3):373-85. PubMed ID: 6187038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
    Magnussen I; Jensen TS; Rand JH; Van Woert MH
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W; Pagliusi SR; Müller F
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.
    Gijsman HJ; van Gerven JM; de Kam ML; Schoemaker RC; Pieters MS; Weemaes M; de Rijk R; van der Post J; Cohen AF
    J Clin Psychopharmacol; 2002 Apr; 22(2):183-9. PubMed ID: 11910264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man.
    Joseph MH; Baker HF
    Clin Chim Acta; 1976 Oct; 72(1):125-31. PubMed ID: 1086173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of aromatic amino acid decarboxylase inhibitors on plasma concentrations of 5-hydroxytryptophan in man.
    Magnussen I; Engbaek F
    Acta Pharmacol Toxicol (Copenh); 1978 Jul; 43(1):36-42. PubMed ID: 309271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-5-hydroxytryptophan does not stimulate LH secretion directly from the pituitary in patients with gonadotrophin releasing hormone deficiency.
    Lado-Abeal J; Graña M; Rey C; Cabezas-Cerrato J
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):203-7. PubMed ID: 9828908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester.
    Korf J; Sebens JB; Venema K; van Praag HM
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):171-82. PubMed ID: 968174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism.
    Nutt JG; Woodward WR; Anderson JL
    Ann Neurol; 1985 Nov; 18(5):537-43. PubMed ID: 4073849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenously administered L-5-hydroxytryptophan in man.
    Magnussen I; Nielsen-Kudsk F
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):308-14. PubMed ID: 311987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the effects of 5-hydroxytryptophan on the secretion of ACTH and growth hormone in dogs are not mediated by central release of serotonin.
    Zimmermann H; Kaplan SL; Ganong WF
    Neuroendocrinology; 1982 Jan; 34(1):27-31. PubMed ID: 6276803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat.
    Limón-Bernal E; Roa-Coria JE; Zúñiga-Romero Á; Huerta-Cruz JC; Ruíz-Velasco IRC; Flores-Murrieta FJ; Lara-Padilla E; Reyes-García JG; Rocha-González HI
    Behav Pharmacol; 2021 Aug; 32(5):368-381. PubMed ID: 33660661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.
    van Vliet IM; Slaap BR; Westenberg HG; Den Boer JA
    Eur Neuropsychopharmacol; 1996 May; 6(2):103-10. PubMed ID: 8791035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):199-202. PubMed ID: 6334429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.